2m 2m 2m 2m 2m 2m 2m
Nunzia Pharma-A (NUNZ)
OTC
$0.0001$0.00 (0.00%)
Price as of Jan 21, 2026- $43,451.00Market Cap
- 9,900.00%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Nunzia Pharma-A (NUNZ)
$0.0001$0.00 (0.00%)
NUNZ | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.00 | ||
Change | $0.00 (0.00%) | ||
Open | $0.00 | ||
High | $0.00 | ||
Low | $0.00 | ||
Previous Close | $0.00 | ||
Volume | 1,000 | ||
30-Day Average Volume | 3,584 | ||
1-Week Change | 0.00% | ||
1-Month Change | 9,900.00% | ||
1-Year Change | 9,900.00% | ||
3-Year Change | -99.83% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 434.5M | ||
Total Assets | $35,373.00 | ||
Market Cap | $43,451.00 | ||
Enterprise Value | $155,923.00 | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$236,416.00 | ||
Free Cash Flow | -$113,088.00 | ||
EBIT | -$236,416.00 | ||
EBITDA | -$236,416.00 | ||
Net Working Capital | -$196,321.00 | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -0 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -0 | ||
Price/Operating Cash Flow | -0 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||